Progressive spinal muscular atrophies

Journal of Child Neurology

Volumn 14, Issue 11, 1999, Pages 691-695

  Strober, Jonathan B ^a,b   Tennekoon, Gihan I ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME 5Q; CLINICAL FEATURE; DISEASE COURSE; GENE LOCATION; HUMAN; MOTOR NERVE CONDUCTION; MUSCLE BIOPSY; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SCOLIOSIS; SPINAL MUSCULAR ATROPHY;

EID: 0032703659     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901401101     Document Type: Review

References (45)

1. Gamstorp I: Historical review of the progressive spinal muscular atrophy (atrophies) with onset in infancy or early childhood, in Gamstorp I, Sarnat HB (eds): Progressive Spinal Muscular Atrophy. New York, Raven Press, 1984, pp 11-18.
2. Kugelberg E, Welander L: Heredofamilial juvenile muscular atrophy simulating muscular dystrophy. Arch Neural Psychiatry 1956;75:500-509.
3. Wohlfart G, Fex J, Eliasson S: Hereditary proximal spinal muscular atrophy - a clinical entity simulating progressive muscular dystrophy. Acta Psychiatria Neurol Scand 1955;30:395-406.
4. Dubowitz V: Chaos in the classification of SMA: A possible resolution. Neuromuscul Disord 1995;5:3-5.
5. Pearn JH: Incidence, prevalence and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 1978;15:409-413.
6. Crawford TO, Pardo CA: The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 1996;3:97-110.
7. Melki J: Spinal muscular atrophy. Curr Opin Neurol 1997;10: 381-385.
8. Chang J, Jong Y, Lin S, et al: Molecular analysis of survival motor neuron (SMN) and neuronal apoptosis inhibitory protein (NAIP) genes of spinal muscular atrophy patients and their parents. Hum Genet 1997;100:577-581.
9. Iannacone ST: Spinal muscular atrophy. Semin Neurol 1998;18: 19-26.
10. Hausmanova-Petrusewicz I, Zaremba J, Borkowska J, et al: Chronic proximal spinal muscular atrophy of childhood and adolescence: Sex influence. J Med Genet 1984;21:447-450.
11. Munsat TL: Workshop report. International SMA collaboration. Neuromuscul Disord 1991;1:81-92.
12. Munsat T, Davies KE: Spinal muscular atrophy, in Emery AEH (ed): Diagnostic Criteria for Neuromuscular Disorders. Baarn, The Netherlands, European Neuromuscular Center, 1994, pp 48-54.
13. Morrison KE, Harding AE: Disorders of the motor neurone. Baillieres Clin Neurol 1994;3:431-445.
14. Zerres K, Rudnik-Schoneborn S: Natural history in proximal spinal muscular atrophy. Arch Neurol 1995;52:518-523.
15. Russman BS, Buncher CR, White MS, et al: Function changes in spinal muscular atrophy II and III. Neurology 1996;47:973-976.
16. Duckett S: Pediatric Neuropathology. Philadelphia, Williams & Wilkins, 1995.
17. Lo AC, Houenou LJ, Oppenheim RW: Apoptosis in the nervous system: Morphological features, methods, pathology, and prevention. Arch Histol Cytol 1995;58:139-149.
18. Hamburger V: Regression versus peripheral control of differentiation in motor hyperplasia. Am J Anal 1958;102:365-410.
19. Hollyday M, Hamburger V: Reduction of the naturally occurring motor neuron loss by enlargement of the periphery. J Comp Neurol 1976;170:311-320.
20. Harriman DGF: Diseases of muscle, in Adams HJ, Duchen LW (eds): Greenfield's Neuropathology. New York, Oxford University Press, 1992, pp 1411-1500.
21. Fidzianska-Dolot A, Hausmanowa-Petrusewicz I: Morphology of the lower motor neuron and muscle, in Gamstorp I, Sarnat HB (eds): Progressive Spinal Muscular Atrophy. New York, Raven Press, 1984, pp 55-89.
22. Bolton C: Spinal muscular atrophies of childhood and adolescence, in Jones HR, Bolton CF, Harper CM (eds): Pediatric Clinical Electromyography. Philadelphia, Lippincott-Raven, 1996, pp 105-122.
23. Dumitru D: Electrodiagnostic Medicine. Philadelphia, Hanley & Belfus, 1994.
24. Gath I, Sjaastad O, Loken AG: Myopathic electromyographic changes correlated with histopathology in Wohlfart-Kugelberg-Welander disease. Neurology 1969;19:344-352.
25. Brzustowicz LM, Lehner T, Castilla LH, et al: Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 1990;344:540-541.
26. Melki J, Abdelhak S, Sheth P, et al: Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 1990;344: 767-768.
27. Gilliam TC, Brzustowicz LM, Castilla LH, et al: Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Nature 1990;345:823-825.
28. Melki J, Sheth P, Abdelhak S, et al: Mapping of acute (type 1) spinal muscular atrophy to chromosome 5q12-q14. Lancet 1990;326: 271-273.
29. Lefebvre S, Burglen L, Reboullet S, et al: Identification and characterization of a spinal muscular atrophy determining gene. Cell 1995;80:155-165.
30. Cobben JM, van der Steege G, Grootscholten P, et al: Deletions of the survival motor neuron gene (SMN) in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet 1995; 57:805-808.
31. Wang CH, Xu J, Carter TA, et al: Characterization of survival motor neuron (SMN) gene deletions in asymptomatic carriers of spinal muscular atrophy. Hum Mol Genet 1996;5:359-365.
32. Lefebvre S, Burlet P, Liu Q, et al: Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997;16: 265-269.
33. Roy N, Mahadevan MS, McLean M, et al: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995;80:167-178.
34. Marshall CR: Medical treatment of spinal muscular atrophy, in Gamstorp I, Sarnat HB (eds): Progressive Spinal Muscular Atrophy. New York, Raven Press, 1984, pp 163-171.
35. Thoenen H, Hughes RA, Sendtner M: Trophic support of motoneurons: Physiological, pathophysiological and therapeutic implications. Exp Neurol 1993;124:47-55.
36. Oppenheim RW, Qin-Wei Y, Prevette D, Yan Q: Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 1992;360:755-757.
37. Arakawa Y, Sendtner M, Thoenen H: Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: Comparison with other neurotrophic factors and cytokines. J Neurosci 1990;10:3507-3515.
38. Sendtner M, Dittrich F, Hughes RA, Thoenen H: Actions of CNTF and neurotrophins on degenerating motoneurons: Preclinical studies and clinical implications. J Neurol Sci 1994;124(Suppl): 77-83.
39. Hugon J: ALS therapy: Targets for the future. Neurology 1996; 47(Suppl 4):S251-S253.
40. Oppenheim RW, Houenou LJ, Johnson JE, et al: Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 1995;373:344-346.
41. Shaw PJ, Forrest V: CSF and plasma amino acid levels in motor neuron disease: Elevation of CSF glutamate in a subset of patients. Neurodegeneration 1995;4:209-216.
42. Rothstein JD, Jin L, Hosler B, et al: Chronic glutamate uptake inhibition produces a model of slow neurotoxicity. Proc Natl Acad Sci 1993;90:6591-6595.
43. Iwasaki Y, Ikeda K, Shiojima T, Kinoshita M: CNQX prevents spinal motor neuron death following sciatic nerve transection in newborn rats. J Neurol Sci 1995;134:21-25.
44. Greensmith L, Vrbova G: Possible strategies for treatment of SMA patients: A neurobiologist's view. Neuromuscul Disord 1995;5: 359-369.
45. Bensimon G, Lacomblez L, Meininger V and the ALS/Riluzole Study Group: A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994:330;585-591.